<prompt> Infliximab is contraindicated inCrohns diseaseIntestinal tuberculosisAnkylosing spondylitisRheumatoid arthritis  <response>: B Intestinal tuberculosis Infliximab is a drug used to treat autoimmune disorders. Infliximab is known as a chimeric monoclonal antibody the term chimeric refers to the use of both mouse murine and human components of the drug i.e. murine binding Fab domains and human constant Fc domains. Case studies have been done into other uses of infliximab, such as to treat skin diseases. Infliximab has been approved for treating ankylosing spondylitis, Crohns disease, fistulizing Crohns disease, pediatric Crohns disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis. Infliximab is also prescribed out of indication for the treatment of Behcets disease and infusions of infliximab have been used successfully in the treatment of sciatica due to slipped discs 